Results 1 to 10 of about 80,375 (245)

Protective Efficacy of H9N2 Avian Influenza Vaccines Inactivated by Ionizing Radiation Methods Administered by the Parenteral or Mucosal Routes [PDF]

Frontiers in Veterinary Science, 2022
H9N2 viruses have become, over the last 20 years, one of the most diffused poultry pathogens and have reached a level of endemicity in several countries.
Alessio Bortolami, Eva Mazzetto, Richard Thiga Kangethe, Viskam Wijewardana, Mario Barbato, Mario Barbato, Luca Porfiri, Silvia Maniero, Elisa Mazzacan, Jane Budai, Sabrina Marciano, Valentina Panzarin, Calogero Terregino, Francesco Bonfante, Giovanni Cattoli   +14 more
doaj   +2 more sources

Quality control procedure for Coccidial vaccines versus different routes of immunization [PDF]

Veterinary World, 2022
Background and Aim: Coccidiosis is an enteric infection caused by a protozoon (Eimeria tenella). Coccidiosis is known to have a negative impact on the economy. Coccidiosis is controlled using anticoccidial drugs, antibiotics, and vaccines.
Arwa Elnaggar, Hala Mahmoud, Sahar Saber
doaj   +1 more source

30-Year Development of Inactivated Virus Vaccine in China

Pharmaceutics, 2023
Inactivated vaccines are vaccines made from inactivated pathogens, typically achieved by using chemical or physical methods to destroy the virus’s ability to replicate.
Jinrong Shi, Ailin Shen, Yao Cheng, Chi Zhang, Xiaoming Yang   +4 more
doaj   +1 more source

A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations

Vaccines, 2023
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and vaccination is critical for preventing further spread or resurgence of the outbreak ...
Lidan Hu, Jingmiao Sun, Yan Wang, Danny Tan, Zhongkai Cao, Langping Gao, Yuelin Guan, Xiuwei Jia, Jianhua Mao   +8 more
doaj   +1 more source

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine

Emerging Microbes and Infections, 2021
Since the outbreak of COVID-19, a variety of vaccine platforms have been developed. Amongst these, inactivated vaccines have been authorized for emergency use or conditional marketing in many countries.
Jialu Zhang, Qian He, Chaoqiang An, Qunying Mao, Fan Gao, Lianlian Bian, Xing Wu, Qian Wang, Pei Liu, Lifang Song, Yaqian Huo, Siyuan Liu, Xujia Yan, Jinghuan Yang, Bopei Cui, Changgui Li, Junzhi Wang, Zhenglun Liang, Miao Xu   +18 more
doaj   +1 more source

Analysing transcriptomic signatures and identifying potential genes for the protective effect of inactivated COVID-19 vaccines [PDF]

PeerJ, 2023
Inactivated vaccines are one of the most effective strategies for controlling the coronavirus disease 2019 (COVID-19) pandemic. However, the response genes for the protective effect of inactivated vaccines are still unclear.
Hongquan Chen, Lu Zhang, Chen Xu, Xiaoyun Shen, Jiazhou Lou, Shengjun Wu   +5 more
doaj   +2 more sources

Inactivated vaccine against Aujeszky's disease

Veterinary World, 2021
Background and Aim: The Aujeszky's disease, also known as Pseudorabies, remains one of the most problematic fulminant diseases in domestic animals, affecting the central nervous system. The study aimed to investigate the effect of an inactivated vaccine against Aujeszky's disease based on "Kordai" virus strain.
Zhanat B. Kondibaeva, Bolat A. Yespembetov, Khairulla B. Abeuov, Assiya K. Mussayeva, Sarsenbek T. Siyabekov, Saltanat T. Nussupova, Elmira K. Akmatova, Yerlan K. Pazylov, Kydyrbay T. Maikhin, Nazym S. Syrym   +9 more
openaire   +4 more sources

EVALUATION OF RECOMBINANT AVIAN INFLUENZA COMPARED TO INACTIVATED VACCINES TO INDUCE IMMUNE RESPONSE IN CHICKEN [PDF]

Arab Universities Journal of Agricultural Sciences, 2018
The present Avian Influenza epidemic in Egypt is consider one of the major problems facing the poultry field and caused by circulation of genetically and antigenetically diverse influenza H5N1 viruses.
Dalia Omar, K. El-Dougdoug, B. Othman
doaj   +1 more source

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines

Expert Review of Vaccines, 2023
Introduction Approximately half of the 13.4 billion COVID-19 vaccine doses administered globally were inactivated or viral vector platforms. The harmonization and optimization of vaccine regimens has become a key focus of policymakers and health-care ...
Anthony M. Marchese, Raj Kalkeri, Muruga Vadivale, Nungruthai Suntronwong, Seth Toback, Yong Poovorawan   +5 more
doaj   +1 more source

Methodology of Purification of Inactivated Cell-Culture-Grown SARS-CoV-2 Using Size-Exclusion Chromatography

Vaccines, 2022
Various types of COVID-19 vaccines, including adenovirus, mRNA, and inactivated ones, have been developed and approved for clinical use worldwide. Inactivated vaccines are produced using a proven technology that is widely used for the production of ...
Anastasia A. Kovpak, Anastasia N. Piniaeva, Oleg A. Gerasimov, Irina O. Tcelykh, Mayya Y. Ermakova, Anna N. Zyrina, Dmitry V. Danilov, Yury Y. Ivin, Liubov I. Kozlovskaya, Aydar A. Ishmukhametov   +9 more
doaj   +1 more source